This study was supported by the National Institutes of Health [T32 CA96520 to S.C., and R21 NS073702 (2011–2013), R21 NS078226 (2012–2014), and R01 NS075212 (2012–2017) to E.E.U.] and an award from the Guillain–Barré syndrome/Chronic Inflammatory Demyelinating Polyradiculoneuropathy Foundation International (2010–2012).
The role of chemokines in guillain–barré syndrome
Article first published online: 27 JUL 2013
Copyright © 2013 Wiley Periodicals, Inc.
Muscle & Nerve
Volume 48, Issue 3, pages 320–330, September 2013
How to Cite
Chiang, S. and Ubogu, E. E. (2013), The role of chemokines in guillain–barré syndrome. Muscle Nerve, 48: 320–330. doi: 10.1002/mus.23829
Disclosure: The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.
- Issue published online: 27 AUG 2013
- Article first published online: 27 JUL 2013
- Accepted manuscript online: 28 FEB 2013 07:17AM EST
- Manuscript Accepted: 22 FEB 2013
Options for accessing this content:
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!